Purchase Order HHSN269201500268P

This is a $54,558.50 time and materials purchase order awarded by the National Cancer Institute (NCI) to Biomedical Research Alliance of New York LLC (BRANY), a small business contractor. The contract is for BRANY to serve as a Centralized Institutional Review Board (CIRB) to review minimal risk registry linkage studies, which is a key component of NCI's Virtual Pooled Registry Cancer Linkage System (VPR-CLS). The CIRB is intended to streamline the IRB application and review process, thereby...

This delivery order was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to IIT Research Institute under the CRO Support for NCATS In Vitro and In Vivo Toxicology Studies contract vehicle. IIT Research Institute will perform a single-dose cardiovascular and pulmonary safety pharmacology study of Metarrestin in telemetered beagle dogs using a Latin square crossover study design. The $130,092.52 cost-plus-fixed-fee contract is funded by...

This is a Cost Plus Fixed Fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Technical Resources International, Inc. (Technical Resources Intl), a minority-owned, woman-owned, Hispanic American-owned small business. The contract, with a ceiling value of $74,513,740.28, is for Clinical Research Organization (CRO) assistance in support of the ACTIV-1 Master Protocol, a clinical trial initiative. The contract is a Delivery Order under the Medical...

This is a $115,518,487 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI) to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned small business. The contract provides clinical trials sponsor and regulatory management support services to the NCI, the Center for Cancer Research (CCR), and CCR investigators. The contract includes services such as compliance with U.S. and international regulations, regulatory support,...

This is a firm fixed price delivery order awarded by the National Cancer Institute, part of the Department of Health and Human Services National Institutes of Health, to IIT Research Institute. The order is for preclinical efficacy evaluation of a lipid-based SMEDDS formulation of the drug compound DIM, BR-9001, as part of the NCI's Preclinical Prevent Cancer Program. The $970,988.47 contract has a completion date of February 7, 2022. IIT Research Institute is a non-profit research...

This federal contract award is for MEDICAL EXPERT WITNESS VICP- CASE # 2104050026, 2104060023, 2104090010, 2104150002, 2106230028, 2106220026, 2107020013, 2107220020, 2110010017,2111090027, with a ceiling value of $99,992.00. The contract was awarded to J29, Inc., a government-focused information technology organization that specializes in data management, claims analytics, program assurance, and artificial intelligence use cases. J29, Inc. holds certifications as an SBA 8(a) Program...

This is a $1,010.00 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for a "Kick Off Meeting, Preclinical Pharmacokinetic & Pharmacology Evaluations of Agents Being Developed for Cancer Patients" with a performance period from July 1, 2016 to September 30, 2016. This work is being performed under NCI's Pharmacokinetic and Pharmacology Evaluations for...

This firm-fixed price purchase order was awarded by the Northeast Area division of the Federal Agency to Medstar Health Research Institute Inc., a non-profit research organization and subsidiary of Medstar Health. The $15,440.00 contract is for Institutional Review Board (IRB) reviews, with a period of performance through September 23, 2016. No set-aside was used for this award. Medstar Health Research Institute has an extensive history of providing clinical research and healthcare services to...

The National Cancer Institute awarded a $1.98 million firm fixed-price delivery order to IIT Research Institute (IITRI) on September 17, 2018, for preclinical studies supporting clinical trial development of an MPGES-1/5-LOX inhibitor therapeutic candidate. The contract, which was ultimately completed by July 25, 2025, was performed at IITRI's Chicago, Illinois facility and encompassed toxicology and pharmacology testing services required to support investigational new drug applications and...

This is a $547,860 delivery order contract awarded by the National Cancer Institute (NCI) of the Department of Health and Human Services (HHS) to The Institute for Cancer Research, a non-profit research organization. The contract is part of the Preclinical Efficacy and Intermediate Endpoint Biomarkers indefinite delivery vehicle, which supports the PREVENT Cancer Preclinical Drug Development Program. Under this 5-year IDIQ, The Institute for Cancer Research provides preclinical efficacy...